Cargando…

Effect of saxagliptin on the expression of HIF-1α in the liver of diabetic rats with fatty liver

The present study was designed to establish a rat model of type 2 diabetes mellitus (T2DM) complicated with fatty liver and to detect the expression of hypoxia-inducible factor-1α (HIF-1α) in liver tissue during the treatment with saxagliptin. Eighty male Wistar rats were randomly divided into two g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qian, Xiao, Qian, Meng, Xiangying, Chen, Jianyang, Ye, Weiwei, Zhou, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122484/ https://www.ncbi.nlm.nih.gov/pubmed/30186489 http://dx.doi.org/10.3892/etm.2018.6473

Ejemplares similares

Kombiglyze (metformin and saxagliptin)‐induced hepatotoxicity in a patient with non‐alcoholic fatty liver disease
por: Thalha, Abdul Malik, et al.
Publicado: (2018)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
por: Chen, Lin, et al.
Publicado: (2020)

Expression of Notch–Hif-1α signaling pathway in liver regeneration of rats
por: Li, Yanshan, et al.
Publicado: (2020)

Saxagliptin for type 2 diabetes
por: Chacra, Antonio R
Publicado: (2010)

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production
por: Ma, Zhenhua, et al.
Publicado: (2017)

Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes
por: Ye, Weiwei, et al.
Publicado: (2022)

Hif-2α regulates lipid metabolism in alcoholic fatty liver disease through mitophagy
por: Wu, Mei-fei, et al.
Publicado: (2022)

Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
por: Johansson, Lars, et al.
Publicado: (2020)

The Suppressive Effect of Resveratrol on HIF-1α and VEGF Expression after Warm Ischemia and Reperfusion in Rat Liver
por: Zhang, Mei, et al.
Publicado: (2014)

Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy
por: Chang, Yun-peng, et al.
Publicado: (2017)

Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
por: Neumiller, Joshua J.
Publicado: (2014)

HIF-1α expression in liver metastasis but not primary colorectal cancer is associated with prognosis of patients with colorectal liver metastasis
por: Wada, Yuma, et al.
Publicado: (2020)

Saxagliptin Restores Vascular Mitochondrial Exercise Response in the Goto-Kakizaki Rat
por: Keller, Amy C., et al.
Publicado: (2015)

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
por: Sui, Yi, et al.
Publicado: (2019)

HIF-1α regulates A2B adenosine receptor expression in liver cancer cells
por: Kwon, Jae Hyun, et al.
Publicado: (2019)

Saxagliptin Induces β-Cell Proliferation through Increasing Stromal Cell-Derived Factor-1α In Vivo and In Vitro
por: Li, Chun-Jun, et al.
Publicado: (2017)

Role of saxagliptin as monotherapy or adjunct therapy in the treatment of type 2 diabetes
por: Sharma, Morali D
Publicado: (2010)

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
por: Cobble, Michael E, et al.
Publicado: (2012)

Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
por: Kulasa, Kristen, et al.
Publicado: (2010)

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients
por: Konya, Hiroyuki, et al.
Publicado: (2014)

Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
por: Elgart, Jorge F, et al.
Publicado: (2013)

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
por: Ott, Christian, et al.
Publicado: (2014)

Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
por: Jain, Rajeev
Publicado: (2015)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
por: Minze, Molly G., et al.
Publicado: (2013)

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
por: Birnbaum, Yochai, et al.
Publicado: (2016)

Ursolic acid sensitizes radioresistant NSCLC cells expressing HIF-1α through reducing endogenous GSH and inhibiting HIF-1α
por: Song, Bing, et al.
Publicado: (2017)

Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
por: ElBaset, Marwan A., et al.
Publicado: (2022)

Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver
por: Knudsen, Anders R, et al.
Publicado: (2011)

Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
por: Hu, Xiao-Qian, et al.
Publicado: (2010)

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
por: Gallwitz, Baptist
Publicado: (2010)

Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination
por: Panagoulias, George S, et al.
Publicado: (2014)

Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
por: Perl, Shira, et al.
Publicado: (2016)

The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study
por: Balkau, Beverley, et al.
Publicado: (2017)

Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
por: Liu, Yan-Mei, et al.
Publicado: (2016)

Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis
por: Men, Peng, et al.
Publicado: (2018)

Effect of anti‐oxidants, Ricetrienol and α‐tocopherol, on adipocytokine abnormalities and fatty liver in Otsuka Long‐Evans Tokushima Fatty diabetic rats
por: Tatsumi, Kunihiro, et al.
Publicado: (2010)

Curcumin Protects against CCl(4)-Induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-Dependent Pathway
por: Zhao, Yanling, et al.
Publicado: (2014)

Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
por: Li, Hongxue, et al.
Publicado: (2021)

Efficacy and short-term side effects of sitagliptin, vildagliptin and saxagliptin in Chinese diabetes: a randomized clinical trial
por: Zhou, Xiao-jun, et al.
Publicado: (2019)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1n32m8mfte7ekuof9eq54qnnoj